174 related articles for article (PubMed ID: 15233578)
1. Pharmacological treatments of cerebellar ataxia.
Ogawa M
Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cerebellar ataxia with 5-HT1A agonist.
Takei A; Hamada T; Yabe I; Sasaki H
Cerebellum; 2005; 4(3):211-5. PubMed ID: 16147954
[TBL] [Abstract][Full Text] [Related]
3. Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease.
Schulte T; Mattern R; Berger K; Szymanski S; Klotz P; Kraus PH; Przuntek H; Schöls L
Arch Neurol; 2001 Sep; 58(9):1451-7. PubMed ID: 11559318
[TBL] [Abstract][Full Text] [Related]
4. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
Wessel K; Hermsdörfer J; Deger K; Herzog T; Huss GP; Kömpf D; Mai N; Schimrigk K; Wittkämper A; Ziegler W
Arch Neurol; 1995 May; 52(5):451-5. PubMed ID: 7733838
[TBL] [Abstract][Full Text] [Related]
5. Choline chloride in the treatment of cerebellar and spinocerebellar ataxia.
Livingstone IR; Mastaglia FL; Pennington RJ; Skilbeck C
J Neurol Sci; 1981 May; 50(2):161-74. PubMed ID: 7229661
[TBL] [Abstract][Full Text] [Related]
6. Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia.
Trouillas P; Xie J; Adeleine P
Prog Brain Res; 1997; 114():589-99. PubMed ID: 9193169
[TBL] [Abstract][Full Text] [Related]
7. [Physostigmine in treatment of cerebellar ataxia].
Aschoff JC; Kailer NA; Walter K
Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
[TBL] [Abstract][Full Text] [Related]
8. Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy.
Trouillas P; Xie J; Adeleine P; Michel D; Vighetto A; Honnorat J; Dumas R; Nighoghossian N; Laurent B
Arch Neurol; 1997 Jun; 54(6):749-52. PubMed ID: 9193210
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.
Trouillas P; Brudon F; Adeleine P
Arch Neurol; 1988 Nov; 45(11):1217-22. PubMed ID: 3190503
[TBL] [Abstract][Full Text] [Related]
10. Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.
Wessel K; Langenberger K; Nitschke MF; Kömpf D
Arch Neurol; 1997 Apr; 54(4):397-400. PubMed ID: 9109740
[TBL] [Abstract][Full Text] [Related]
11. [Effect of buspirone, a serotonergic 5-HT-1A agonist in cerebellar ataxia: a pilot study. Preliminary communication].
Trouillas P; Xie J; Getenet JC; Adeleine P; Nighoghossian N; Honnorat J; Riche G; Derex L
Rev Neurol (Paris); 1995 Dec; 151(12):708-13. PubMed ID: 8787101
[TBL] [Abstract][Full Text] [Related]
12. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.
Manyam BV; Giacobini E; Ferraro TN; Hare TA
Arch Neurol; 1990 Nov; 47(11):1194-9. PubMed ID: 1978660
[TBL] [Abstract][Full Text] [Related]
14. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration.
Ogawa M; Shigeto H; Yamamoto T; Oya Y; Wada K; Nishikawa T; Kawai M
J Neurol Sci; 2003 Jun; 210(1-2):53-6. PubMed ID: 12736088
[TBL] [Abstract][Full Text] [Related]
15. [Theoretical basis and proposals for neuropharmacology of cerebellar ataxia].
Trouillas P
Rev Neurol (Paris); 1993; 149(11):637-46. PubMed ID: 7916472
[No Abstract] [Full Text] [Related]
16. Efficacy of thyrotropin-releasing hormone in the treatment of cerebellar ataxia.
Takeuchi Y; Fujiwara K; Ishimura K; Shimada Y; Ochi M; Yoshioka H; Sawada T
Pediatr Neurol; 1989; 5(2):107-10. PubMed ID: 2469426
[TBL] [Abstract][Full Text] [Related]
17. Oral choline in cerebellar ataxia.
Sehested P; Lund HI; Kristensen O
Acta Neurol Scand; 1980 Aug; 62(2):124-6. PubMed ID: 7211160
[TBL] [Abstract][Full Text] [Related]
18. Contrast sensitivity improvement with sulfamethoxazole and trimethoprim in a patient with Machado-Joseph disease without spasticity.
Azulay JP; Blin O; Mestre D; Sangla I; Serratrice G
J Neurol Sci; 1994 May; 123(1-2):95-9. PubMed ID: 8064328
[TBL] [Abstract][Full Text] [Related]
19. The use of choline chloride in ataxic disorders.
Lawrence CM; Millac P; Stout GS; Ward JW
J Neurol Neurosurg Psychiatry; 1980 May; 43(5):452-4. PubMed ID: 6999128
[TBL] [Abstract][Full Text] [Related]
20. Physostigmine in familial ataxias.
Kark RA; Blass JP; Spence MA
Neurology; 1977 Jan; 27(1):70-2. PubMed ID: 556821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
